Intersect ENT (NASDAQ:XENT) is a commercial drug-device company that has developed a drug releasing bioabsorbable implant technology, which enables targeted and sustained release of therapeutic agents. This technology is designed to help ear, nose and throat or ENT physicians to improve patient care, specifically aiding in the treatment of chronic sinusitis. According to....More>>>
For nearly the entire month of October, gold has been “stuck” in a trading range.
The precious metal has been meandering between $1,250 and $1,275, seemingly directionless. But our newest gold price forecast shows a scenario where gold climbs by double digits in the next several months.
The big story this month has been the surging U.S. dollar,....More>>>
Although the S&P 500 closed slightly lower Thursday, the index is still near its all time high as investors continue to enjoy an 8-year bull market.
However, many equity analysts remain cautious as stocks appear to be trading at inflated multiples. Goldman Sachs even went on record saying that they believe the U.S. bull market is in its last few innings.
Related CTAS 8 Stocks To Watch For March 22, 2017 Earnings Scheduled For March 22, 2017 Cintas Corporation (CTAS) Q3 2017 Results – Earnings Call Transcript (Seeking Alpha) Related GME Earnings Scheduled For March 23, 2017....More>>>
One of the advantages of being a dividend investor is that I invest in businesses that meet a certain qualitative and quantitative criteria. This allows me to focus on quality compounding machines with established track records. This discipline also allows me to avoid overpaying for those companies.
Even the best company in the world is not worth overpaying for. Another trait....More>>>